Novel Harmonization Method for Multi-Centric Radiomic Studies in Non-Small Cell Lung Cancer.

computed tomography (ct) imaging biomarkers and radiomics machine learning multi-modality ct-positron emission tomography (pet) non-small-cell lung cancer quantitative imaging/analysis stereotactic body radiation therapy (sbrt)

Journal

Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503

Informations de publication

Date de publication:
22 07 2022
Historique:
received: 02 05 2022
revised: 08 07 2022
accepted: 14 07 2022
entrez: 27 7 2022
pubmed: 28 7 2022
medline: 29 7 2022
Statut: epublish

Résumé

The purpose of this multi-centric work was to investigate the relationship between radiomic features extracted from pre-treatment computed tomography (CT), positron emission tomography (PET) imaging, and clinical outcomes for stereotactic body radiation therapy (SBRT) in early-stage non-small cell lung cancer (NSCLC). One-hundred and seventeen patients who received SBRT for early-stage NSCLC were retrospectively identified from seven Italian centers. The tumor was identified on pre-treatment free-breathing CT and PET images, from which we extracted 3004 quantitative radiomic features. The primary outcome was 24-month progression-free-survival (PFS) based on cancer recurrence (local/non-local) following SBRT. A harmonization technique was proposed for CT features considering lesion and contralateral healthy lung tissues using the LASSO algorithm as a feature selector. Models with harmonized CT features (B models) demonstrated better performances compared to the ones using only original CT features (C models). A linear support vector machine (SVM) with harmonized CT and PET features (A1 model) showed an area under the curve (AUC) of 0.77 (0.63-0.85) for predicting the primary outcome in an external validation cohort. The addition of clinical features did not enhance the model performance. This study provided the basis for validating our novel CT data harmonization strategy, involving delta radiomics. The harmonized radiomic models demonstrated the capability to properly predict patient prognosis.

Identifiants

pubmed: 35892979
pii: curroncol29080410
doi: 10.3390/curroncol29080410
pmc: PMC9332210
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5179-5194

Références

J Clin Oncol. 2001 Jan 1;19(1):127-36
pubmed: 11134205
IEEE Access. 2018;6:77796-77806
pubmed: 30607311
Med Phys. 2021 Oct;48(10):6257-6269
pubmed: 34415574
J Pers Med. 2021 Aug 27;11(9):
pubmed: 34575619
J Med Invest. 2019;66(1.2):35-37
pubmed: 31064950
Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):448-56
pubmed: 20971575
ESMO Open. 2018 Apr 13;3(3):e000344
pubmed: 29682332
Medicine (Baltimore). 2020 Aug 21;99(34):e21715
pubmed: 32846789
Lung Cancer. 2003 Jul;41(1):1-11
pubmed: 12826306
Sci Rep. 2017 Apr 3;7(1):588
pubmed: 28373718
Ann Thorac Surg. 1995 Sep;60(3):615-22; discussion 622-3
pubmed: 7677489
Radiother Oncol. 2021 Feb;155:188-203
pubmed: 33096167
EPMA J. 2013 Feb 25;4(1):7
pubmed: 23442211
Radiother Oncol. 2015 Feb;114(2):148-54
pubmed: 25586951
J Clin Oncol. 2014 Sep 10;32(26):2847-54
pubmed: 25113761
Int J Mol Imaging. 2013;2013:980769
pubmed: 23533750
Clin Radiol. 2004 Dec;59(12):1061-9
pubmed: 15556588
Jpn J Clin Oncol. 2018 Feb 01;48(2):160-166
pubmed: 29253245
Int J Radiat Oncol Biol Phys. 2015 Sep 1;93(1):82-90
pubmed: 26138912
Chest. 2003 Nov;124(5):1946-55
pubmed: 14605072
Int J Radiat Oncol Biol Phys. 2014 Sep 1;90(1):203-8
pubmed: 25015198
Acta Oncol. 2003;42(8):882-94
pubmed: 14968949
Int J Radiat Oncol Biol Phys. 2021 May 1;110(1):160-171
pubmed: 30954520
Phys Med Biol. 2016 Jul 7;61(13):R150-66
pubmed: 27269645
AJR Am J Roentgenol. 2019 Aug;213(2):349-357
pubmed: 31012758
J Thorac Cardiovasc Surg. 2000 Jan;119(1):21-6
pubmed: 10612756
PLoS One. 2015 Dec 15;10(12):e0145063
pubmed: 26669541
Int J Radiat Oncol Biol Phys. 2020 Jan 1;106(1):90-99
pubmed: 31586665
Cancer Res. 2017 Nov 1;77(21):e104-e107
pubmed: 29092951
JAMA. 2010 Mar 17;303(11):1070-6
pubmed: 20233825
Eur J Cancer. 2012 Mar;48(4):441-6
pubmed: 22257792
Lung Cancer. 2009 Nov;66(2):262-7
pubmed: 19299032
Sci Rep. 2020 Jun 24;10(1):10248
pubmed: 32581221
Semin Thorac Cardiovasc Surg. 2010 Spring;22(1):44-52
pubmed: 20813316
Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e299-303
pubmed: 21477948
Oncotarget. 2017 Jun 27;8(26):43169-43179
pubmed: 28574816
Ann Oncol. 2017 Jun 1;28(6):1191-1206
pubmed: 28168275
Radiology. 1999 Nov;213(2):317-20
pubmed: 10551208
Radiother Oncol. 2017 Jul;124(1):1-10
pubmed: 28666551
Chest. 2013 Jun;143(6):1784-1790
pubmed: 23732589
J Thorac Oncol. 2007 Jul;2(7 Suppl 3):S94-100
pubmed: 17603311
Int J Radiat Oncol Biol Phys. 2009 Nov 1;75(3):677-82
pubmed: 19251380
Med Oncol. 2020 Mar 31;37(5):38
pubmed: 32236847
CA Cancer J Clin. 2013 Jan;63(1):11-30
pubmed: 23335087
Lung Cancer. 2018 Nov;125:185-191
pubmed: 30429018
Nat Rev Clin Oncol. 2017 Dec;14(12):749-762
pubmed: 28975929

Auteurs

Marco Bertolini (M)

S.C. Fisica Medica, Azienda USL-IRCCS di Reggio Emilia, 42124 Reggio Emilia, Italy.

Valeria Trojani (V)

S.C. Fisica Medica, Azienda USL-IRCCS di Reggio Emilia, 42124 Reggio Emilia, Italy.

Andrea Botti (A)

S.C. Fisica Medica, Azienda USL-IRCCS di Reggio Emilia, 42124 Reggio Emilia, Italy.

Noemi Cucurachi (N)

S.C. Fisica Medica, Azienda USL-IRCCS di Reggio Emilia, 42124 Reggio Emilia, Italy.

Marco Galaverni (M)

S.C. Radioterapia, Azienda Ospedaliero-Universitaria Maggiore, 43126 Parma, Italy.

Salvatore Cozzi (S)

S.C. Radioterapia, Azienda USL-IRCCS di Reggio Emilia, 42124 Reggio Emilia, Italy.

Paolo Borghetti (P)

Department of Radiation Oncology, University and Spedali Civili Hospital, 25123 Brescia, Italy.

Salvatore La Mattina (S)

Department of Radiation Oncology, University and Spedali Civili Hospital, 25123 Brescia, Italy.

Edoardo Pastorello (E)

Department of Radiation Oncology, University and Spedali Civili Hospital, 25123 Brescia, Italy.

Michele Avanzo (M)

Medical Physics Department, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy.

Alberto Revelant (A)

Radiation Oncology Department, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy.

Matteo Sepulcri (M)

Radiotherapy, Veneto Institute of Oncology IOV-IRCCS, 35128 Padova, Italy.

Chiara Paronetto (C)

Radiotherapy, Veneto Institute of Oncology IOV-IRCCS, 35128 Padova, Italy.

Stefano Ursino (S)

Department of Radiation Oncology, Santa Chiara University Hospital, 56100 Pisa, Italy.

Giulia Malfatti (G)

Department of Radiation Oncology, Santa Chiara University Hospital, 56100 Pisa, Italy.

Niccolò Giaj-Levra (N)

Department of Radiation Oncology, IRCCS Sacro Cuore Don Calabria Hospital Negrar, 37024 Verona, Italy.

Lorenzo Falcinelli (L)

Radiation Oncology Section, S. Maria della Misericordia Hospital, 06129 Perugia, Italy.

Cinzia Iotti (C)

S.C. Radioterapia, Azienda USL-IRCCS di Reggio Emilia, 42124 Reggio Emilia, Italy.

Mauro Iori (M)

S.C. Fisica Medica, Azienda USL-IRCCS di Reggio Emilia, 42124 Reggio Emilia, Italy.

Patrizia Ciammella (P)

S.C. Radioterapia, Azienda USL-IRCCS di Reggio Emilia, 42124 Reggio Emilia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH